Vimarsana
Biggest News Aggregation in the World

Outsourding Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outsourding Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outsourding Pharma Today - Breaking & Trending Today

Extensive £30 million ($38 million) study into liver cirrhosis - Vimarsana News

Extensive £30 million ($38 million) study into liver cirrhosis

Published: January 9, 2024

A £30 million ($38 million) study into liver cirrhosis, the most extensive ever conducted worldwide has been announced by Newcastle University and University of Edinburgh, funded by Boehringer Ingelheim.

Source: biopharma-reporter.com
Related Topics:
City OfUnited KingdomQuentin AnsteeLykke Hinsch GylvinOutsourding PharmaNeil HendersonNewcastle UniversityUniversity Of EdinburghBoehringer IngelheimHinsch GylvinNewcastle HospitalsEdinburgh InnovationsMarkets Amp RegulationsEmerging MarketsCell Amp Gene TherapiesLiver DiseaseClinical Trials
Extensive £30 million ($38 million) study into liver cirrhosis - Vimarsana News

Extensive £30 million ($38 million) study into liver cirrhosis

Published: January 8, 2024

A £30 million ($38 million) study into liver cirrhosis, the most extensive ever conducted worldwide has been announced by Newcastle University and University of Edinburgh, funded by Boehringer Ingelheim.

Source: outsourcing-pharma.com
Related Topics:
City OfUnited KingdomLykke Hinsch GylvinQuentin AnsteeNeil HendersonOutsourding PharmaUniversity Of EdinburghNewcastle UniversityBoehringer IngelheimHinsch GylvinNewcastle HospitalsEdinburgh InnovationsClinical EvolutionPreclinical ResearchClinical DevelopmentAtient CentricityLiver DiseaseClinical Trials